You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Theophylline 0.32% And Dextrose 5% In Plastic Container

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	CAMP Steering Committee	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Theophylline 0.32% And Dextrose 5% In Plastic Container

Condition Name

Chart
Table

Condition Name for Theophylline 0.32% And Dextrose 5% In Plastic Container
Intervention	Trials
Asthma	22
Chronic Obstructive Pulmonary Disease	9
COPD	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Theophylline 0.32% And Dextrose 5% In Plastic Container
Intervention	Trials
Asthma	20
Lung Diseases	18
Pulmonary Disease, Chronic Obstructive	18
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Theophylline 0.32% And Dextrose 5% In Plastic Container

Trials by Country

Map
Table

Trials by Country for Theophylline 0.32% And Dextrose 5% In Plastic Container
Location	Trials
United States	141
China	24
Japan	19
Canada	13
United Kingdom	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Theophylline 0.32% And Dextrose 5% In Plastic Container
Location	Trials
California	13
Colorado	11
Texas	10
Missouri	9
Tennessee	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Theophylline 0.32% And Dextrose 5% In Plastic Container

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Theophylline 0.32% And Dextrose 5% In Plastic Container
Clinical Trial Phase	Trials
Phase 4	20
Phase 3	19
Phase 2/Phase 3	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Theophylline 0.32% And Dextrose 5% In Plastic Container
Clinical Trial Phase	Trials
Completed	68
Unknown status	14
Recruiting	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Theophylline 0.32% And Dextrose 5% In Plastic Container

Sponsor Name

Chart
Table

Sponsor Name for Theophylline 0.32% And Dextrose 5% In Plastic Container
Sponsor	Trials
National Heart, Lung, and Blood Institute (NHLBI)	10
Boehringer Ingelheim	4
Washington University School of Medicine	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Theophylline 0.32% And Dextrose 5% In Plastic Container
Sponsor	Trials
Other	126
Industry	31
NIH	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.